omniture
logo
Search
再鼎医药（上海）有限公司 ZAI LABORATORY
Media Room

Latest News

rss

Zai Lab Announces First Quarter 2022 Financial Results and Corporate Updates

Company to Host Conference Call and Webcast on May 11, 2022, at 8:00 a.m. ET SHANGHAI and SAN FRANC...

2022-05-11 15:13 4137

Zai Lab Announces Financial Results for Six Months Ended June 30, 2020 and Corporate Updates

SHANGHAI and SAN FRANCISCO, Aug. 13, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB), an innova...

2020-08-13 22:38 6582

China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor

SHANGHAI and SAN FRANCISCO and WALTHAM, Mass., July 20, 2020 /PRNewswire/ -- Zai Lab Limited (NASDA...

2020-07-20 22:39 3985

Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement for Repotrectinib in Greater China

SHANGHAI, July 8, 2020 /PRNewswire/ -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision...

2020-07-08 11:37 2397

Zai Lab Announces Positive Topline Results from the NORA Phase 3 Study of ZEJULA® as Maintenance Therapy for Chinese Patients with Platinum-sensitive, Recurrent Ovarian Cancer

SHANGHAI and SAN FRANCISCO, May 29, 2020 /PRNewswire/ -- Zai Lab Limited ("Zai Lab") (NASDAQ: ZLAB)...

2020-05-29 07:05 3282

Zai Lab Announces First Chinese Patient Dosed in the Global Phase 3 ATTACK Trial of Sulbactam- Durlobactam for Patients with Carbapenem-Resistant Acinetobacter Infections

SHANGHAI and SAN FRANCISCO, May 19, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB), an innovat...

2020-05-19 09:45 2735

Zai Lab Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Updates

SHANGHAI and SAN FRANCISCO, March 19, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB), aChina a...

2020-03-20 00:21 3702